{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-115084","form_type":"8-K","ticker":"HQY","cik":"0001428336","company_name":"HEALTHEQUITY, INC.","filed_at":"2026-10-09T21:00:29+00:00","discovered_at":"2026-10-09T21:02:00.254665+00:00","generated_at":"2026-10-12T15:00:55.655693+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"HealthEquity CCO Michael Fiore terminated without cause, effective Oct 5, 2026; no successor named","bullets":["Michael Fiore, Chief Commercial Officer of HealthEquity, was terminated by the company without cause, effective October 5, 2026.","The Chief Commercial Officer responsibilities will be redistributed to other members of HealthEquity's management team; no replacement was named.","Fiore will receive previously negotiated severance payments and benefits under his employment agreement, as detailed in the company's proxy statement filed May 13, 2026.","Severance is conditioned on a release of claims against the company and continued compliance with restrictive covenants in his employment agreement.","Outstanding equity awards will be treated consistent with HealthEquity's 2014 and 2024 Stock Incentive Plans and his applicable award agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-115084","json":"https://secwatch.observer/filing/0001104659-26-115084.json","markdown":"https://secwatch.observer/filing/0001104659-26-115084.md","text":"https://secwatch.observer/filing/0001104659-26-115084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/0001104659-26-115084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/tm2627329d1_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T15:00:55.655693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8df4026f12","claim":"Michael Fiore was terminated as Chief Commercial Officer at HEALTHEQUITY, INC..","evidence_excerpt":"The employment of Michael Fiore, the Chief Commercial Officer at HealthEquity, Inc. (the “Company”), was terminated by the Company without cause, effective October 5, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1428336/000110465926115084/0001104659-26-115084-index.htm","confidence":0.97,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Commercial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}